trending Market Intelligence /marketintelligence/en/news-insights/trending/FGRZH3AzOrhlzHzlR7KTyA2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Mylan investors urged to jettison most board nominees by proxy adviser

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Mylan investors urged to jettison most board nominees by proxy adviser

Proxy adviser Institutional Shareholder Services urged shareholders to vote against 10 of Mylan NV's 11 director nominees, saying the board mismanaged the controversy involving company's EpiPen treatment, Reuters reported June 12.

Ahead of company's June 22 shareholder meeting, Institutional Shareholder Services recommended voting against nominees including CEO Heather Bresch, President Rajiv Malik and Chairman Robert Coury. The proxy firm also advised investors to vote against executive pay packages.

Institutional Shareholder Services said the shareholder value had eroded as the board failed to adequately manage the situation. No candidates have been named as replacements, Reuters reported.

The company is confident its shareholders recognize that the board has overseen "a period of strong and sustainable long-term growth," Nina Devlin, Mylan's spokeswoman, said in a statement. Devlin added that the recommendation to remove the board and leave the company without any leadership is not in shareholders' best interests, Reuters reported.

Glass Lewis & Co., another proxy firm, also advised Mylan shareholders against voting for the chairman's pay, and against three of the directors on the compensation committee, according to Reuters.

The recommendations come after a group of institutional investors opposed the re-election of Coury and five other directors due to a disagreement over high executive pay.